Yellow Fever Outbreak Toolbox
Updated | March 2024
Welcome to the Yellow Fever Outbreak Toolbox
Key reference documents
- Yellow fever fact sheet (Geneva: World Health Organization).
- Yellow fever information page (Geneva: World Health Organization).
- Yellow fever health topic page (Brazzaville: World Health Organization).
- Yellow fever (Washington (DC): Pan American Health Organization; 2019).
Case definitions
WHO suggested outbreak case definition1
Any person with acute onset of fever, with jaundice appearing within 14 days of onset of the first symptoms.
1. A probable case; and
Absence of yellow fever immunization within 30 days before onset of illness; and one of the following:
- detection of yellow fever-specific IgM;2 or
- detection of fourfold increase in yellow fever IgM, or IgG antibody titres between acute and convalescent serum samples, or both; or
- detection of yellow fever-specific neutralizing antibodies.
or
- detection of yellow fever virus genome in blood or other organs by polymerase chain reaction (PCR); or
- detection of yellow fever antigen in blood, liver or other organs by immunoassay; or
- isolation of yellow fever virus.
WHO surveillance case definition3
- Yellow Fever: Vaccine Preventable Diseases Surveillance Standards (Geneva: World Health Organization; 2020).
WHO other definitions
Outbreak definitions:
- Presence of at least one confirmed case of yellow fever, as interpreted in a context of underlying population immunity and risk of onward amplification.
1. Yellow Fever: Vaccine Preventable Diseases Surveillance Standards (Geneva: World Health Organization; 2020)
2. Yellow fever-specific means that the results of antibody tests (such as IgM or neutralizing antibody) for other prevalent flavivirues are negative or not significant. Testing should include at least IgM for dengue fever and West Nile but may include other flaviviruses according to local epidemiology (for example, Zika virus).
3. Yellow fever confirmation is complex:
- Any case classification should account for vaccination status.
- Serological testing cannot distinguish between vaccine- and naturally-acquired antibodies.
- Yellow fever diagnostic is both positive and differential. It is essential to rule out cross-reactivity with other arboviruses such as dengue, zika, chikungunya or West Nile virus This cross-reactivity can be seen on serology testing (IgM) as well as plague reduction neutralization assays (PRNT).
Results should be interpreted considering local epidemiology of other flaviviruses.
Data collection tools
- Case investigation form(s):
- Line list(s): Not available.
- Electronic tools:
- Go. Data yellow fever outbreak template: To download the template and use, kindly email the Go.Data team at godata@who.int
- Go. Data yellow fever outbreak template: To download the template and use, kindly email the Go.Data team at godata@who.int
Laboratory confirmation
- Yellow fever – Investigation of yellow fever epidemics in Africa: Field guide (page 37) (Geneva: World
Health Organization; 2008).
- Laboratory manual for yellow fever (Geneva: World Health Organization; 2024).
- Operational guidance on the use of yellow fever assays in the context of surveillance (Geneva: World Health Organization; 2023).
- EYE.operations: Streamlined international transport mechanism for shipping samples to Regional Reference Laboratories at no cost to countries. Refer to EYE ops document and booking form. Email contact: EYE.ops@who.int
- Eliminate Yellow Fever Strategy - laboratory information (EYE LABS)
Response tools and resources
- Yellow fever – Investigation of yellow fever epidemics in Africa: Field guide (Geneva: World Health Organization; 2008).
- Control of yellow fever: Field guide (page 13) (Washington (DC): Pan American Health Organization; 2005).
- International Coordinating Group (ICG) for emergency provision of yellow fever vaccine.
Training
- Yellow fever: Introductory level online course (Geneva; World Health Organization: 2016).
Other resources
- Eliminate Yellow Fever. A Global strategy to Eliminate Yellow Fever Epidemics (EYE): (Geneva: World Health Organization; 2018).
- Risk communication and community engagement readiness and response toolkit: yellow fever (Geneva: World Health Organization; 2024).
- Yellow fever surveillance and outbreak response: revision of case definitions, October 2010 (Geneva: World Health Organization; 2014).
- Yellow fever: surveillance of adverse events following immunization against yellow fever: field guide for staff at the central, intermediate and peripheral levels (Geneva: World Health Organization; 2010).
- Disease commodity package - Yellow fever (Geneva: World Health Organization; 2018).
- Communication and social mobilization in yellow fever mass vaccination campaigns: 10 points from field experience (Geneva: World Health Organization; 2015).
- Tool for the diagnosis and care of patients with suspected arboviral diseases (page 55) (Washington (DC): Pan American Health Organisation; 2017).
- Yellow fever: rapid field entomological assessment during yellow fever outbreaks in Africa: Handbook: methodological field approaches for scientists with a basic background in entomology (Geneva; World Health Organization; 2014).